PL373834A1 - Sekwencje aminokwasów naśladujące insulinę - Google Patents
Sekwencje aminokwasów naśladujące insulinęInfo
- Publication number
- PL373834A1 PL373834A1 PL02373834A PL37383402A PL373834A1 PL 373834 A1 PL373834 A1 PL 373834A1 PL 02373834 A PL02373834 A PL 02373834A PL 37383402 A PL37383402 A PL 37383402A PL 373834 A1 PL373834 A1 PL 373834A1
- Authority
- PL
- Poland
- Prior art keywords
- amino acid
- acid sequences
- insulin mimetic
- mimetic amino
- insulin
- Prior art date
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title 2
- 102000004877 Insulin Human genes 0.000 title 1
- 108090001061 Insulin Proteins 0.000 title 1
- 125000003275 alpha amino acid group Chemical group 0.000 title 1
- 229940125396 insulin Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4732—Casein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10149668A DE10149668A1 (de) | 2001-10-09 | 2001-10-09 | Insulinmimetische Aminosäuresequenzen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL373834A1 true PL373834A1 (pl) | 2005-09-19 |
Family
ID=7701844
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL02373834A PL373834A1 (pl) | 2001-10-09 | 2002-10-07 | Sekwencje aminokwasów naśladujące insulinę |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20050089969A1 (pl) |
| EP (1) | EP1434797A2 (pl) |
| DE (1) | DE10149668A1 (pl) |
| PL (1) | PL373834A1 (pl) |
| RU (1) | RU2004114236A (pl) |
| WO (1) | WO2003031472A2 (pl) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003299568B2 (en) * | 2002-11-27 | 2010-07-22 | Ampio Pharmaceuticals, Inc. | Treatment of diseases and conditions mediated by increased phosphorylation |
| JP5770411B2 (ja) * | 2005-02-24 | 2015-08-26 | ディーエスエム アイピー アセッツ ビー.ブイ. | グリコマクロペプチド由来の血圧降下ペプチド |
| EP2413720B1 (en) * | 2009-04-02 | 2019-07-17 | Novozymes A/S | Process for making a milk-based protein hydrolysate |
| US9345727B2 (en) | 2013-03-15 | 2016-05-24 | Mead Johnson Nutrition Company | Nutritional compositions containing a peptide component and uses thereof |
| US9352020B2 (en) | 2013-03-15 | 2016-05-31 | Mead Johnson Nutrition Company | Reducing proinflammatory response |
| US9345741B2 (en) | 2013-03-15 | 2016-05-24 | Mead Johnson Nutrition Company | Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof |
| US8889633B2 (en) | 2013-03-15 | 2014-11-18 | Mead Johnson Nutrition Company | Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof |
| US9289461B2 (en) | 2013-03-15 | 2016-03-22 | Mead Johnson Nutrition Company | Reducing the risk of autoimmune disease |
| US9138455B2 (en) | 2013-03-15 | 2015-09-22 | Mead Johnson Nutrition Company | Activating adiponectin by casein hydrolysate |
| EP2944318A1 (en) * | 2014-05-12 | 2015-11-18 | University College Dublin | Peptides and compositions thereof for improvement of glycaemic management in a mammal |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5538952A (en) * | 1994-05-26 | 1996-07-23 | Abbott Laboratories | Inhibition of infection of mammalian cells by respiratory syncytial virus |
| US5643880A (en) * | 1994-05-26 | 1997-07-01 | Abbott Laboratories | Product for inhibition of attachment of H. influenzae to human cells |
| EP0789842B1 (en) * | 1994-11-04 | 2009-09-09 | A2 Corporation Limited | Method of selecting non-diabetogenic milk or milk products and milk or milk products so selected |
| EP0817967A4 (en) * | 1995-03-31 | 2000-05-17 | Merck & Co Inc | TEST FOR INSULIN-IMITATING AND REINFORCING SUBSTANCES |
| US6287866B1 (en) * | 1996-11-27 | 2001-09-11 | Abbott Laboratories | β-casein expressing constructs |
| GB9828559D0 (en) * | 1998-12-23 | 1999-02-17 | Rademacher Group Limited | Insulin mimetics from honey |
-
2001
- 2001-10-09 DE DE10149668A patent/DE10149668A1/de not_active Withdrawn
-
2002
- 2002-10-07 WO PCT/EP2002/011214 patent/WO2003031472A2/de not_active Ceased
- 2002-10-07 RU RU2004114236/13A patent/RU2004114236A/ru not_active Application Discontinuation
- 2002-10-07 EP EP02777293A patent/EP1434797A2/de not_active Withdrawn
- 2002-10-07 PL PL02373834A patent/PL373834A1/pl unknown
- 2002-10-07 US US10/476,184 patent/US20050089969A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003031472A3 (de) | 2004-03-25 |
| DE10149668A1 (de) | 2003-04-10 |
| EP1434797A2 (de) | 2004-07-07 |
| WO2003031472A2 (de) | 2003-04-17 |
| US20050089969A1 (en) | 2005-04-28 |
| RU2004114236A (ru) | 2005-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI315201B (en) | Acidic insulin preparations having improved stability | |
| IL157705A0 (en) | Igf antagonist peptides | |
| EP1352661A4 (en) | INJECTIONS FOR ENDOSCOPY | |
| PL373834A1 (pl) | Sekwencje aminokwasów naśladujące insulinę | |
| GB0100196D0 (en) | Peptides | |
| GB0201679D0 (en) | Polypeptide variants | |
| GB0117011D0 (en) | Peptide barrels | |
| PL366425A1 (pl) | Peptydy wykazujące aktywność hamującą wytwarzanietlenku azotu | |
| AU2003210778A8 (en) | Amino acid transporters | |
| IL158742A0 (en) | Peptides for use as translocation factors | |
| GB0109438D0 (en) | Peptides | |
| AU2002338872A1 (en) | Insulin mimetic amino acid sequences | |
| GB0126164D0 (en) | Sequences | |
| AU2003276846A8 (en) | Thrombopoiesis-stimulating proteins having reduced immunogenicity | |
| AU2003220217A8 (en) | Identifying peptide modifications | |
| GB0118113D0 (en) | Subcutaneous tunnelling | |
| GB0111194D0 (en) | Sequences | |
| GB0103517D0 (en) | Polypeptide | |
| HUP0303523A3 (en) | Modified insulin with reduced immunogenicity | |
| AU2003244403A1 (en) | Trans-splicing ribozymes transferring elements derived from sequences encoding fluorescent proteins | |
| NZ513990A (en) | Novel nucleotide and amino acid sequences | |
| EP1373306A4 (en) | PROTEINS ASSOCIATED WITH CYTOSKELETON | |
| GB0308404D0 (en) | Polypeptide sequences | |
| GB0308406D0 (en) | Polypeptide sequences | |
| GB0126165D0 (en) | Sequences |